Post by alice on Sept 8, 2020 15:07:57 GMT -5
New Research 9/03/2020
To help accelerate the development of treatments for Alzheimer’s disease, the Alzheimer’s Association’s Part the Cloud research grant program is investing $24 million in clinical trials investigating 16 potential therapies. Scientists from around the world will use the funds to conduct Phase 1 and 2 trials testing a variety of experimental medications and devices. The studies involve prospective treatments that focus on how brain cells use energy and fuel, and how they extract waste and debris from the brain. They also explore how blood supply in the brain is maintained. “We must leave no stone unturned when it comes to finding treatments for Alzheimer’s and all other dementia, and Part the Cloud is designed to explore every feasible option in order to drive research forward to get potential treatment options to people living with Alzheimer’s faster,” Maria C. Carrillo, PhD, the Alzheimer’s Association chief science officer, said in a press release. Led by philanthropist Mikey Hoag, the grant program supports early-stage clinical investigations with the goal of slowing, stopping, or impeding Alzheimer’s progression.
To help accelerate the development of treatments for Alzheimer’s disease, the Alzheimer’s Association’s Part the Cloud research grant program is investing $24 million in clinical trials investigating 16 potential therapies. Scientists from around the world will use the funds to conduct Phase 1 and 2 trials testing a variety of experimental medications and devices. The studies involve prospective treatments that focus on how brain cells use energy and fuel, and how they extract waste and debris from the brain. They also explore how blood supply in the brain is maintained. “We must leave no stone unturned when it comes to finding treatments for Alzheimer’s and all other dementia, and Part the Cloud is designed to explore every feasible option in order to drive research forward to get potential treatment options to people living with Alzheimer’s faster,” Maria C. Carrillo, PhD, the Alzheimer’s Association chief science officer, said in a press release. Led by philanthropist Mikey Hoag, the grant program supports early-stage clinical investigations with the goal of slowing, stopping, or impeding Alzheimer’s progression.
I am no longer able to hold your hand my beloved but I cherish the remembrance of your hand in mine...and the wonderful person that touched so many lives with joy. : )